Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07222176 · ClinicalTrials.gov registry record · NA

Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles

A NA study of Periocular Fine Wrinkles, sponsored by Main Line Center for Laser Surgery.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07222176 is a NA study of Periocular Fine Wrinkles that is active but no longer recruiting, run by Main Line Center for Laser Surgery. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07222176, a NA study of Periocular Fine Wrinkles, is active but no longer recruiting, sponsored by Main Line Center for Laser Surgery.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study looks at whether using a cosmeceutical called P-TIOX together with a treatment called Tixel can reduce fine lines and wrinkles around the eyes better than Tixel treatment alone. Tixel is an FDA-approved device that uses heat to improve skin texture and firmness. P-TIOX is a topical product with ingredients that may help improve the skin's appearance and elasticity. One side of the face will be treated with both P-TIOX and Tixel, while the other side will receive Tixel only. The study will last about 9 weeks and will include several treatments and evaluations using photos and expert assessments. Participants may notice improvement in the skin around their eyes. The results will help doctors understand if this combination treatment is more effective.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT Split-Face Tixel Treatment With and Without Topical Peptide-Based Cosmeceutical (P-TIOX)

Study Locations (1)

Pennsylvania

  • Main Line Center for Laser Surgery - Ardmore

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-06-01
Est. Completion 2027-06-01
Phase NA

What the Registry Record Tells You About NCT07222176

The ClinicalTrials.gov registry entry for NCT07222176 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Main Line Center for Laser Surgery, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Periocular Fine Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Split-Face Tixel Treatment With and Without Topical Peptide-Based Cosmeceutical (P-TIOX) is the first listed.

NCT07222176 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07222176 about?

NCT07222176 is a clinical study titled "Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles". This study looks at whether using a cosmeceutical called P-TIOX together with a treatment called Tixel can reduce fine lines and wrinkles around the eyes better than Tixel treatment alone. Tixel is an FDA-approved device that uses heat to improve skin texture and firmness. P-TIOX is a topical produc...

What is the current status of trial NCT07222176?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-01. Estimated completion is 2027-06-01.

What conditions does trial NCT07222176 study?

This clinical trial studies the following conditions: Periocular Fine Wrinkles.

What interventions are being tested in trial NCT07222176?

The interventions under investigation include: Split-Face Tixel Treatment With and Without Topical Peptide-Based Cosmeceutical (P-TIOX) (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT07222176?

This trial is sponsored by Main Line Center for Laser Surgery, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07222176 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.